Navigation Links
Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
Date:12/12/2007

silencing can be used to: 1) identify biological processes that are essential for growth and persistence of mycobacteria during infections in the mouse; 2) genetically mimic the action of antibiotics on the progression of M. tuberculosis infections and thus aid the prioritization of drug targets; and 3) study the function of essential genes using functional genomics.

Dr. Nathan's and Dr. Schnappinger's grants are two of 11 new grants, totaling $280 million, by the Gates Foundation to speed research and development on promising vaccines, diagnostic tests and treatments to help reduce the global TB burden.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
2. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
3. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
4. Healthy restaurants help make us fat, says a new Cornell study
5. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
6. DaVita Receives Civil Complaint
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
8. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
9. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
10. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2Americans United for Lifes Statement on Finance Committee Vote 59407 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 2New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 3